| Surya P Irakam, MD | |
|
25 Monroe St, Bridgewater, NJ 08807-3043 | |
| (908) 231-1999 | |
| (908) 231-1612 |
| Full Name | Surya P Irakam |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 33 Years |
| Location | 25 Monroe St, Bridgewater, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114971397 | NPI | - | NPPES |
| 9101608 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MA06747400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Peter's University Hospital | New brunswick, NJ | Hospital |
| Robert Wood Johnson University Hospital - Somerset | Somerville, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Consensus Medical Group Llc | 2961748181 | 137 |
News Archive
Now, a new study published on the preprint server medRxiv* in June 2020 reports that viral RNA has been found to occur in HVAC (Heating, Ventilation, and AC) units in healthcare facilities. However, it is not clear if this represents a possible mechanism of viral transmission.
Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.
Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains.
All-terrain vehicles (ATVs) were introduced in this country in the 1970s. Currently, there are approximately 9.5 million ATVs in use and more than 150,000 reported ATV-related injuries in this country annually. The rapid rise in ATV-related injuries is due to increased use and also to the production of larger, faster, and more powerful vehicles, according to a review article that was recently published in the April issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.
› Verified 1 days ago
| Entity Name | Consensus Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811466881 PECOS PAC ID: 2961748181 Enrollment ID: O20190109001851 |
News Archive
Now, a new study published on the preprint server medRxiv* in June 2020 reports that viral RNA has been found to occur in HVAC (Heating, Ventilation, and AC) units in healthcare facilities. However, it is not clear if this represents a possible mechanism of viral transmission.
Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.
Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains.
All-terrain vehicles (ATVs) were introduced in this country in the 1970s. Currently, there are approximately 9.5 million ATVs in use and more than 150,000 reported ATV-related injuries in this country annually. The rapid rise in ATV-related injuries is due to increased use and also to the production of larger, faster, and more powerful vehicles, according to a review article that was recently published in the April issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Surya P Irakam, MD 25 Monroe St, Bridgewater, NJ 08807-3043 Ph: (908) 231-1999 | Surya P Irakam, MD 25 Monroe St, Bridgewater, NJ 08807-3043 Ph: (908) 231-1999 |
News Archive
Now, a new study published on the preprint server medRxiv* in June 2020 reports that viral RNA has been found to occur in HVAC (Heating, Ventilation, and AC) units in healthcare facilities. However, it is not clear if this represents a possible mechanism of viral transmission.
Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma, according to a new study.
Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains.
All-terrain vehicles (ATVs) were introduced in this country in the 1970s. Currently, there are approximately 9.5 million ATVs in use and more than 150,000 reported ATV-related injuries in this country annually. The rapid rise in ATV-related injuries is due to increased use and also to the production of larger, faster, and more powerful vehicles, according to a review article that was recently published in the April issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.
› Verified 1 days ago
Indravadan Ishwarbhai Patel, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 66 Shaffer Rd, Bridgewater, NJ 08807 Phone: 908-392-6635 | |
Dr. Izzat H Shah, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1121 Route 22 Ste 201, Bridgewater, NJ 08807 Phone: 908-237-4110 | |
Lawrence Steven Perlow, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1384 Plymouth Rd, Bridgewater, NJ 08807 Phone: 908-231-0329 | |
Dr. Ranjita Sengupta, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 465 Union Ave, Suite A, Bridgewater, NJ 08807 Phone: 908-722-6410 Fax: 908-722-4638 | |
Dr. Alpesh A Patel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 245 Union Ave Ste 1a, Bridgewater, NJ 08807 Phone: 908-864-4027 Fax: 732-463-5510 | |
Dr. Glenn T Friedman, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 225 Jackson Street, Bridgewater, NJ 08807 Phone: 908-526-8668 Fax: 908-231-6781 | |
Dr. Chandreshwar N Shahi, MD, FACC Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 245 Union Ave, Suite 1a, Bridgewater, NJ 08807 Phone: 908-864-4027 Fax: 908-864-4029 |